Sooyoung Shin
- Pharmaceutical Science top 5%
-
- Diabetes Treatment and Management 5
- Diabetes Management and Research 4
- Pharmacology top 10%
- Gastroenterology top 10%
-
- Pharmacovigilance and Adverse Drug Reactions 7
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Atrial Fibrillation Management and Outcomes 4
-
- Metabolism, Diabetes, and Cancer 5
-
- Lipoproteins and Cardiovascular Health 4
-
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Yeo Jin ChoiSang‐Min JeonXinjun LiJin‐Seok ChoiYoon YeoSukhyang LeeYoung‐Joon ParkMichael D. Tsifansky
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Sooyoung Shin
54 papers receiving 930 citations
Peers
Comparison fields: 5 of 109
- Pharmaceutical Science 69
- Endocrinology, Diabetes and Metabolism 182
- Pharmacology 63
- Physiology 187
- Gastroenterology 35
Countries citing papers authored by Sooyoung Shin
This map shows the geographic impact of Sooyoung Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sooyoung Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sooyoung Shin more than expected).
Fields of papers citing papers by Sooyoung Shin
This network shows the impact of papers produced by Sooyoung Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sooyoung Shin. The network helps show where Sooyoung Shin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sooyoung Shin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 1 | |
| 10 | 2020 | 2 | |
| 11 | 2020 | 138 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 5 | |
| 14 | 2018 | 4 | |
| 15 | 2018 | 30 | |
| 16 | 2017 | 4 | |
| 17 | 2015 | 17 | |
| 18 | 2015 | 31 | |
| 19 | Evaluation of Pharmacy Students’ Attitudes Toward Pharmaceutical Care and Career Choices Following Interdisciplinary Inpatient Clerkships | 2014 | 3 |
| 20 | 2006 | 148 |
About Sooyoung Shin
Sooyoung Shin is a scholar working on Toxicology, Endocrinology, Diabetes and Metabolism and Issues, ethics and legal aspects, having authored 58 papers that have together received 947 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Metabolism, Diabetes, and Cancer (5 papers), Diabetes Treatment and Management (5 papers), Atrial Fibrillation Management and Outcomes (4 papers), Lipoproteins and Cardiovascular Health (4 papers), Diabetes Management and Research (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). The work is most often cited by research in Pharmaceutical Science (69 citations), Endocrinology, Diabetes and Metabolism (182 citations) and Pharmacology (63 citations). Sooyoung Shin has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Yeo Jin Choi, Sang‐Min Jeon, Xinjun Li, Jin‐Seok Choi, Yoon Yeo, Sukhyang Lee, Young‐Joon Park, Michael D. Tsifansky, Yan Yang and Hyun Jung Koo. Their work appears in journals such as PLoS ONE, Scientific Reports and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.